Liminatus Pharma, Inc. (LIMN)
0.22
-0.02
(-7.68%)
USD |
NASDAQ |
Feb 20, 16:00
0.225
0.00 (0.00%)
After-Hours: 20:00
Liminatus Pharma EPS Diluted (TTM) : -0.1853 for Sept. 30, 2025
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| CDT Equity, Inc. | -266.63 |
| LENZ Therapeutics, Inc. | -2.108 |
| Oruka Therapeutics, Inc. | -2.417 |
| Maze Therapeutics, Inc. | -2.254 |
| MapLight Therapeutics, Inc. | -2.352 |